BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34496060)

  • 21. Non-invasive prediction of persistent villous atrophy in celiac disease.
    Packova B; Kovalcikova P; Pavlovsky Z; Bartusek D; Prokesova J; Dolina J; Kroupa R
    World J Gastroenterol; 2020 Jul; 26(26):3780-3791. PubMed ID: 32774057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten-free diet.
    O'Morain N; Shannon E; McManus J; Warner V; Leeson H; O'Donovan H; Egan B; Byrnes V
    United European Gastroenterol J; 2021 Oct; 9(8):973-979. PubMed ID: 34185963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of the BioPlex 2200 Celiac IgA and IgG Kits - a novel multiplex screen incorporating an integral check for IgA deficiency.
    Holding S; Wilson F; Spradbery D
    J Immunol Methods; 2014 Mar; 405():29-34. PubMed ID: 24424297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of Serologic Change to Gluten in Celiac Disease Patients.
    Syage J; Ramos A; Loskutov V; Norum A; Bledsoe A; Choung RS; Dickason M; Sealey-Voyksner J; Murray J
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease.
    Spatola BN; Kaukinen K; Collin P; Mäki M; Kagnoff MF; Daugherty PS
    Aliment Pharmacol Ther; 2014 Feb; 39(4):407-17. PubMed ID: 24392888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to deamidated gliadin peptides: an accurate predictor of coeliac disease in infancy.
    Amarri S; Alvisi P; De Giorgio R; Gelli MC; Cicola R; Tovoli F; Sassatelli R; Caio G; Volta U
    J Clin Immunol; 2013 Jul; 33(5):1027-30. PubMed ID: 23558824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
    Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
    Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies.
    Tesei N; Sugai E; Vázquez H; Smecuol E; Niveloni S; Mazure R; Moreno ML; Gomez JC; Mauriño E; Bai JC
    Aliment Pharmacol Ther; 2003 Jun; 17(11):1415-23. PubMed ID: 12786636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.
    Hoerter NA; Shannahan SE; Suarez J; Lewis SK; Green PHR; Leffler DA; Lebwohl B
    Dig Dis Sci; 2017 May; 62(5):1272-1276. PubMed ID: 28161854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimising the follow-up of adult coeliac disease with a clinical-based score to identify patients in need of a histological reassessment: a retrospective single centre study.
    Harder G; Schiepatti A; Biagi F; Borrelli de Andreis F; Agazzi S; Gabrielli GM; Klersy C
    Br J Nutr; 2020 May; 123(10):1159-1164. PubMed ID: 32077407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth.
    Dickey W; Hughes DF; McMillan SA
    Scand J Gastroenterol; 2000 Feb; 35(2):181-3. PubMed ID: 10720117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Concentrations Decrease 14-Fold in Children With Celiac Disease on a Gluten-Free Diet but Remain High at 3 Months.
    Petroff D; Wolf J; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Heiduk M; Flemming G; Schmidt A; Hasenclever D; Mothes T
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1442-1449.e5. PubMed ID: 29654912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
    Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
    Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.
    Lau MS; Mooney P; White W; Appleby V; Moreea S; Haythem I; Elias J; Bundhoo K; Corbett G; Wong L; Tsai HH; Cross S; Hebden J; Hoque S; Sanders D
    BMC Gastroenterol; 2016 Sep; 16():115. PubMed ID: 27628523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early diagnosis of celiac disease in IgA deficient children: contribution of a point-of-care test.
    Bienvenu F; Anghel SI; Besson Duvanel C; Guillemaud J; Garnier L; Renosi F; Lachaux A; Bienvenu J
    BMC Gastroenterol; 2014 Nov; 14():186. PubMed ID: 25376178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
    Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
    Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
    Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
    Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic performances of celiac disease serological tests among Saudi patients.
    Sghiri R; Hassine HB; Almogren A; Shakoor Z; Alswayyed M
    Saudi J Gastroenterol; 2023; 29(1):31-38. PubMed ID: 36571384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
    Agardh D
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.